ATE233551T1 - Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung - Google Patents

Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung

Info

Publication number
ATE233551T1
ATE233551T1 AT95932094T AT95932094T ATE233551T1 AT E233551 T1 ATE233551 T1 AT E233551T1 AT 95932094 T AT95932094 T AT 95932094T AT 95932094 T AT95932094 T AT 95932094T AT E233551 T1 ATE233551 T1 AT E233551T1
Authority
AT
Austria
Prior art keywords
control
inflammation
levels
altering
oxygenase activity
Prior art date
Application number
AT95932094T
Other languages
English (en)
Inventor
Dean Willis
Adrian Richard Moore
Derek Albert Willoughby
Original Assignee
William Harvey Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4154382&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE233551(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by William Harvey Res Ltd filed Critical William Harvey Res Ltd
Application granted granted Critical
Publication of ATE233551T1 publication Critical patent/ATE233551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Rear-View Mirror Devices That Are Mounted On The Exterior Of The Vehicle (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT95932094T 1994-09-22 1995-09-22 Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung ATE233551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002132690A CA2132690A1 (en) 1994-09-22 1994-09-22 Control and modulation of inflammatory response in humans in need of such control and modulation
PCT/GB1995/002249 WO1996009038A2 (en) 1994-09-22 1995-09-22 Alteration of activity and/or levels of haem-oxygenase to control inflammation

Publications (1)

Publication Number Publication Date
ATE233551T1 true ATE233551T1 (de) 2003-03-15

Family

ID=4154382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932094T ATE233551T1 (de) 1994-09-22 1995-09-22 Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung

Country Status (12)

Country Link
EP (1) EP0782441B1 (de)
JP (1) JPH10506388A (de)
CN (1) CN1213742C (de)
AT (1) ATE233551T1 (de)
AU (1) AU3528195A (de)
CA (1) CA2132690A1 (de)
DE (1) DE69529831T2 (de)
DK (1) DK0782441T3 (de)
ES (1) ES2192205T3 (de)
NZ (1) NZ292963A (de)
PT (1) PT782441E (de)
WO (1) WO1996009038A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5756492A (en) * 1996-09-09 1998-05-26 Sangstat Medical Corporation Graft survival prolongation with porphyrins
DE69813898T2 (de) 1997-11-03 2004-03-11 Duke University Substituierte porphyrinen
DK1071474T3 (da) 1998-04-24 2006-04-10 Univ Duke Substituerede porphyriner
JP2003500335A (ja) 1998-12-17 2003-01-07 サングスタット メディカル コーポレイション ヘムオキシゲナーゼ活性の調節による移植片の生存を強化する方法
ATE312103T1 (de) 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
EP2319518A1 (de) 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO-freisetzender Verbindungen zur Behandlung entzündlicher Erkrankungen
WO2003088748A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
WO2003103680A1 (en) 2002-06-07 2003-12-18 Duke University Substituted porphyrins
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
CA2624467A1 (en) * 2005-09-30 2007-04-12 Ovation Pharmaceuticals, Inc. Method of treating pancreatitis
DK2300003T3 (da) 2008-05-23 2014-05-26 Nat Jewish Health Forbindelser til anvendelse i behandling af skade forbundet med eksponering for en alkylerende art
CA2789950C (en) * 2010-02-18 2018-09-04 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
PT2699242T (pt) 2011-04-19 2018-01-22 Alfama Inc Moléculas de libertação de monóxido de carbono e utilizações das mesmas
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
CN105727379A (zh) * 2016-02-25 2016-07-06 顾宇春 血红素加氧酶药物洗脱支架
CN110585215B (zh) * 2019-09-19 2023-06-02 中山大学 氯化血红素及其复合物在医药中的新应用
CA3225692A1 (en) * 2021-07-12 2023-01-19 Donald Jeffrey Keyser Metal protoporphyrin for treatment of bk virus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
ES2134804T3 (es) * 1991-04-19 1999-10-16 Childrens Medical Center Uso de un compuesto generador de oxido nitrico para prevenir daño neuronal.
EP0605622B1 (de) * 1991-09-24 1997-11-12 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
AU680222B2 (en) * 1992-12-10 1997-07-24 Hemogen, Inc. Method for stimulating production of heme oxygenase using vitamin B12

Also Published As

Publication number Publication date
DE69529831D1 (de) 2003-04-10
ES2192205T3 (es) 2003-10-01
CN1213742C (zh) 2005-08-10
EP0782441B1 (de) 2003-03-05
CN1166785A (zh) 1997-12-03
JPH10506388A (ja) 1998-06-23
PT782441E (pt) 2003-07-31
WO1996009038A3 (en) 1996-06-13
AU3528195A (en) 1996-04-09
DK0782441T3 (da) 2003-06-30
DE69529831T2 (de) 2003-12-24
NZ292963A (en) 2001-06-29
CA2132690A1 (en) 1996-03-23
EP0782441A1 (de) 1997-07-09
WO1996009038A2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
DE69529831D1 (de) Änderung der aktivität und/oder spiegel von häm-oxygenase zur beherrschung von entzündung
ATE135231T1 (de) Verwendung von ''cartilage-inducing factor'' (cif) zur behandlung von hemato- oder lymphopoietischen krankheiten
DE3584172D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstenone und ihre anwendung als 5-alpha-reduktase-inhibitoren.
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ES2092460T3 (es) Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ATE20185T1 (de) Mittel zur verhuetung und behandlung von leberund nierenkrankheiten.
DE69205859D1 (de) Verwendung von oberflächenaktiven Mitteln zur Verbesserung des Rückflusses von Venenkathetern.
DE69620458D1 (de) Benzofuran-carboxamide und -sulfonamide
DK71387A (da) Terapeutisk middel til behandling af psoriasis
DE60044584D1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
DE3584974D1 (de) Zusammensetzungen von ungesaettigten polyestern oder polyesteramiden mit polycycloalkenylendgruppen und vinylaktive plastifiziermittel dazu.
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
ATE354591T1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
GR80629B (en) Pharmacologically active diarylindane -1,3-diones
DE3674619D1 (de) Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis.
ATE48132T1 (de) Isoxazol- und isothiazolderivate.
ATE141617T1 (de) Kontinuierliche hydrolyse von zelluloseacetat
ATE216884T1 (de) Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden
NO901920L (no) Nye polypeptidforbindelser.
ATE367164T1 (de) Verwendung von 4-thiouridin oder isomaltitol zur behandlung von entzündungen und/oder hämostasis
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0782441

Country of ref document: EP

RZN Patent revoked